DURECT Corporation filed its 10-K on Mar 08, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 USD | -7.88% | +22.58% | +157.63% |
21/05 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
21/05 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+157.63% | 51.21M | |
+16.73% | 121B | |
+13.11% | 107B | |
-5.85% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.04% | 15.31B | |
+1.20% | 14.08B | |
+24.14% | 11.74B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- DURECT Corporation Auditor Raises 'Going Concern' Doubt